Suitability assessment of CD24 targeted-therapy in the cancer patients with COVID-19: Preliminary results from pan-cancer

doi:10.1016/j.jinf.2022.05.030

科研成果详情

名称	Suitability assessment of CD24 targeted-therapy in the cancer patients with COVID-19: Preliminary results from pan-cancer
作者	Bin Wang1; Fu, Jiantao 2,3; Lu, Anqian 1; Yang, Jin 2,3
发表期刊	Journal of Infection;
语种	英语
原始文献类型	Letter
资助项目	Hangzhou Biomedicine and Health Industry Development[2021WJCY019];Zhejiang medical and health technology project[2018PY039];National Natural Science Foundation of China[81772520];Natural Science Foundation of Zhejiang province[LGF19H030004];
出版者	W B SAUNDERS CO LTD
ISSN	0163-4453
EISSN	1532-2742
卷号	85
期号	3
页码	334-363
DOI	10.1016/j.jinf.2022.05.030
页数	4
WOS类目	Infectious Diseases
WOS研究方向	Infectious Diseases
WOS记录号	WOS:001194333000004
收录类别	SCOPUS ; SCIE
发布日期	2022-09-01
URL	查看原文
PubMed ID	35659914
通讯作者地址	[Yang, Jin]Hangzhou Normal Univ, Affiliated Hosp, Dept Translat Med Ctr, Hangzhou 310015, Zhejiang, Peoples R China. ; [Yang, Jin]Hangzhou Normal Univ, Inst Hepatol & Metab Dis, Hangzhou 310015, Zhejiang, Peoples R China.
Scopus学科分类	Microbiology (medical);Infectious Diseases
SCOPUSEID	SCOPUS_ID:85135145324
TOP期刊	TOP期刊
引用统计
文献类型	其他
条目标识符	https://kms.wmu.edu.cn/handle/3ETUA0LF/184776
专题	其他_附属东阳医院（东阳市人民医院）
通讯作者	Yang, Jin
作者单位	1.Wenzhou Med Univ, Affiliated Dongyang Hosp, Dept Hepatobiliary Surg, Dongyang 322100, Zhejiang, Peoples R China; 2.Hangzhou Normal Univ, Affiliated Hosp, Dept Translat Med Ctr, Hangzhou 310015, Zhejiang, Peoples R China; 3.Hangzhou Normal Univ, Inst Hepatol & Metab Dis, Hangzhou 310015, Zhejiang, Peoples R China
第一作者单位	其他_附属东阳医院（东阳市人民医院）
推荐引用方式 GB/T 7714	Bin Wang,Fu, Jiantao,Lu, Anqian,et al. Suitability assessment of CD24 targeted-therapy in the cancer patients with COVID-19: Preliminary results from pan-cancer. 2022.